Intensity Therapeutics upsizes proposed IPO to $15M from $8M (INTS)

Andrey Tolkachev

Oncology drug developer (Intensity Therapeutics)Nasdaq: INTS) increased its proposed initial public offering to $15 million from $8 million.

The biotech company said in an filing that it is now considering offering 3.25 million shares priced between $4 and $5, which would raise about $15 million if priced at

15MIntensityINTSIPOproposedTherapeuticsupsizes
Comments (0)
Add Comment